Skip to main content
SpringerLink
Log in

Carboplatin/docetaxel/erlotinib

Gastrointestinal toxicities (first report of C. septicum infection with erlotinib and carboplatin, and of colonic perforation with erlotinib): 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Holmberg LA, Goff B, Veljovich D.Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer. Gynecologic Oncology 121: 426, No. 2, May 2011. Available from: URL: http://dx.doi.org/10.1016/j.ygyno.2010.11.049 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carboplatin/docetaxel/erlotinib. React. Wkly. 1354, 14 (2011). https://doi.org/10.2165/00128415-201113540-00044

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113540-00044

Keywords

Search

Navigation